TY  - JOUR

T1  - The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAXA (R)

JO  - OSTEOPOROSIS INT

PY  - 2010/03/01

AU  - Borgstrom F

AU  - Strom O

AU  - Coelho J

AU  - Johansson H

AU  - Oden A

AU  - McCloskey EV

AU  - Kanis JA

ED  - 

DO  - DOI: 10.1007/s00198-009-0989-8

VL  - 21

IS  - 3

SP  - 495

EP  - 505

Y2  - 2024/12/22

ER  -